IL6 and asthma: Regarding metabolic syndrome and dyslipidaemia, it has been largely described how they may be associated with asthma, probably due to IL-6 activity originating from activated macrophages, which promotes systemic and pulmonary modulation, as well as due to the oxidative stress and their effect on airway hyper-responsiveness (146–149).